Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer

about

Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer

Item

http://www.wikidata.org/entity/Q58738564

description

article

@en

im November 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Preclinical evidence of the en ...... ICAR in reducing kidney cancer

@en

Preclinical evidence of the en ...... ICAR in reducing kidney cancer

@nl

type

Item

label

Preclinical evidence of the en ...... ICAR in reducing kidney cancer

@en

Preclinical evidence of the en ...... ICAR in reducing kidney cancer

@nl

prefLabel

Preclinical evidence of the en ...... ICAR in reducing kidney cancer

@en

Preclinical evidence of the en ...... ICAR in reducing kidney cancer

@nl

P1476

Preclinical evidence of the en ...... ICAR in reducing kidney cancer

@en

P2093

Boajie Li

http://www.w3.org/2001/XMLSchema#string

Edward A Medina

http://www.w3.org/2001/XMLSchema#string

Samy L Habib

http://www.w3.org/2001/XMLSchema#string

Sitai Liang

http://www.w3.org/2001/XMLSchema#string

P2860

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

Signaling by target of rapamycin proteins in cell growth control

Hypoxia-inducible factors and the response to hypoxic stress

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Renal cell carcinoma: links and risks

Renal cell carcinoma: histological classification and correlation with imaging findings

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.

Response and acquired resistance to everolimus in anaplastic thyroid cancer

P304

1917-1934

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1878-0261.12370

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30107094

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

molecular medicine

P932

6210038

http://www.w3.org/2001/XMLSchema#string